loader image
Sunday, December 21, 2025
79 F
McAllen
- Advertisement -

DHR Health Level I Trauma Center Re-verified

Translate to Spanish or other 102 languages!

DHR Health’s Level I Trauma Center has been re-verified, ensuring patients across the Rio Grande Valley continue to receive the highest level of trauma care close to home. Image courtesy of DHR Health
DHR Health’s Level I Trauma Center has been re-verified, ensuring patients across the Rio Grande Valley continue to receive the highest level of trauma care close to home. Image courtesy of DHR Health
- Advertisement -

EDINBURG, Texas – DHR Health is proud to announce that its Level I Trauma Center has been re-verified by the American College of Surgeons (ACS) and the Texas Department of State Health Services (DSHS). This recognition reaffirms DHR Health’s role as the first hospital in the Rio Grande Valley to earn this designation and underscores its position as a continued leader in delivering the highest level of trauma care in South Texas.

A Level I designation is the highest recognition a trauma center can achieve, reserved for hospitals that provide comprehensive care for the most severe and complex injuries. Re-verification confirms that DHR Health continues to meet the rigorous standards set by the ACS Committee on Trauma and DSHS, including requirements for staffing, resources, training, research, and patient care. From prevention and emergency intervention to surgery, critical care, and rehabilitation, DHR Health remains equipped to provide expert, around-the-clock care.

“Maintaining our Level I Trauma designation is a reflection of our ongoing commitment to excellence. I want to congratulate our physicians, nurses, and staff whose dedication makes this possible. Together, we are leading the way in setting the highest standards of trauma care for South Texas,” said Marissa Castañeda, Senior Executive Vice President at DHR Health.

- Advertisement -

DHR Health first earned Level I status in 2021. Prior to this achievement, many patients with life-threatening injuries had to be transferred nearly 250 miles to San Antonio—an expensive and risky journey for critically ill patients. Today, DHR Health remains one of only 22 Level I Trauma Centers in Texas, serving patients across 14 counties in South Texas. Its readiness to respond at any hour has saved countless lives, ensuring patients receive top-tier treatment close to home.

“For the last four years, no trauma patient in the Valley has had to be transferred hundreds of miles away. We’ve delivered the highest level of trauma care right here at home, and we will continue to do so for years to come,” said Dr. Jeffrey Skubic, Trauma Surgeon and Medical Director of the DHR Health Level I Trauma Center.

As one of the two Level I Trauma Centers in the region, DHR Health continues to invest in innovation, training, and community outreach to strengthen emergency preparedness across South Texas. This reverification not only affirms the hospital’s capabilities, but also reflects its mission to ensure every patient in the Valley has access to world-class trauma care close to home.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×